1-5 of 5
Wissam Assaily
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies

Chewei Anderson Chang, Ethan Emberley, Aloma L. D'Souza, Weilong Zhao, Cormac Cosgrove, Karen Parrish, Diya Mitra, Elmer Payson, Anatol Oleksijew, Paul Ellis, Luis Rodriguez, Ryan Duggan, Cara Hrusch, Loren Lasko, Wissam Assaily, Pingping Zheng, Wei Liu, Axel Hernandez, Jr., Kimberley McCarthy, Zhaomei Zhang, Geunbae Rha, Zhensheng Cao, Yingchun Li, Olivia Perng, Jos Campbell, Gloria Zhang, Tyler Curran, Milan Bruncko, Christopher C. Marvin, Adrian Hobson, Michael McPherson, Tamar Uziel, Marybeth A. Pysz, Xi Zhao, Alex Bankovich, Joel Hayflick, Michael McDevitt, Kevin J. Freise, Susan Morgan-Lappe, James W. Purcell
Journal: Blood
Blood (2024) 144 (7): 757–770.
https://doi.org/10.1182/blood.2024023849
Published: 2024
Includes: Supplemental data
Journal Articles

Subcutaneous Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma from EPCORE NHL-5

Irit Avivi Mazza, Won Seog Kim, Po-Shen Ko, Carlos Grande, David Lavie, David Chism, Mostafa Seliem, Edwin E. Jeng, Neha Joshi, Satya Siddani, Wissam Assaily, Mariana Sacchi, Minh Dinh, Abraham Avigdor
Journal: Blood
Blood (2023) 142 (Supplement 1): 438.
https://doi.org/10.1182/blood-2023-180089
Published: 2023
Journal Articles

Abbv-101, a Highly Potent and Selective Clinical Stage Bruton Tyrosine Kinase Degrader for the Treatment of B-Cell Malignancies

Chin Pan, Tarikere L Gururaja, Haiyan Li, Henry Nguyen, Yongjiao Zhai, Xiaoping Xie, Rong-Xian Ding, Rebecca Mathew, Hana Y Hoh, Zhaozhong J Jia, Bo Liu, Cassandra Shu, Wissam Assaily, Lloyd T Lam, Jacob J Riehm, Claudina Stevenson, Christine Will, Federico Innocenti, Alexey Rivkin
Journal: Blood
Blood (2023) 142 (Supplement 1): 1887.
https://doi.org/10.1182/blood-2023-184835
Published: 2023
Journal Articles

A First-in-Human Phase 1 Study of ABBV-525, a Small-Molecule MALT1 Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Andrew L. Sochacki, Jan A. Burger, Carrianne Ludwig, Wissam Assaily, Wijith Munasinghe, William Pappano, Edward Greenberg, Christine Will, Meghan C. Thompson
Journal: Blood
Blood (2023) 142 (Supplement 1): 3101.
https://doi.org/10.1182/blood-2023-181671
Published: 2023
Journal Articles

A First-in-Human Phase 1 Study of Abbv-319, an Antibody-Drug Conjugate Composed of a CD19 Antibody Linked to a Potent Proprietary Glucocorticoid Receptor Modulator, in Patients with Relapsed or Refractory B-Cell Malignancies

Moshe Levy, Carl Gustafson, James Purcell, Kevin J. Freise, Wissam Assaily, Deanna Brackman, William R. Henner, Michael McDevitt, John Kuruvilla
Journal: Blood
Blood (2022) 140 (Supplement 1): 3746–3747.
https://doi.org/10.1182/blood-2022-166809
Published: 2022